Varian has launched a new version of its Velocity cancer imaging software, which includes Rapidsphere, a module for Y90 Selective Internal Radiation Therapy (SIRT) dosimetry analysis. Rapidsphere provides the ability for cancer care teams to better understand tumor response and normal-tissue toxicity for patients receiving SIRT. This new software module extends Varian's Velocity software to interventional radiologists for use in targeted cancer therapy delivery to patients with liver malignancies. Velocity 4.0 and the Rapidsphere module have received FDA 510(k) clearance.
Rapidsphere runs on the Velocity software platform, which aggregates unstructured treatment and imaging data from diverse systems to show a comprehensive view of a patient's diagnostic imaging and treatment history. Rapidsphere is an integrated image-guided dosimetry system for calculating the absorbed dose using post-treatment emission tomography imaging from Y90 SIRT. Varian recently hosted a webinar on Rapidsphere, available at www.varian.com/rapidsphere/webinar.
"At Varian, we are focused on providing clinicians with powerful and comprehensive solutions that enable them to provide personalized cancer therapy for patients," said Kolleen Kennedy, president of Varian's Oncology Systems business. "Patient-specific 3D imaging and dosimetry for targeted cancer therapy delivery is important for predicting the tumor's response to therapy. The Rapidsphere module is a significant advancement for interventional radiologists performing Y90 SIRT."
Velocity 4.0 incorporates several new features or improved functionalities. Additional new features in Velocity 4.0 include:
For more information on Velocity and Rapidsphere, visit www.varian.com/rapidsphere.Back To Top
Varian launches Velocity 4.0 cancer imaging software with selective internal radiation therapy dosimetry analysis. Appl Rad Oncol.